Effect of fulvestrant in an experimental model of hepato-pulmonary syndrome (HPS) in rats

M. Oswald-Mammosser, S. Rashid, N. Boehm, A. Agin, B. Geny, V. Shini-Kerth, A. Charloux (Strasbourg, Illkirch, France)

Source: Annual Congress 2013 –Pulmonary circulation: basic science
Session: Pulmonary circulation: basic science
Session type: Oral Presentation
Number: 1504
Disease area: Pulmonary vascular diseases

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Oswald-Mammosser, S. Rashid, N. Boehm, A. Agin, B. Geny, V. Shini-Kerth, A. Charloux (Strasbourg, Illkirch, France). Effect of fulvestrant in an experimental model of hepato-pulmonary syndrome (HPS) in rats. Eur Respir J 2013; 42: Suppl. 57, 1504

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of diminazene on monocrotalin-induced pulmonary hypertension rat model
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Hypoxia signaling modulates neutrophil nitric oxide in a zebrafish tuberculosis model
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014


Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

Hepatopulmonary syndrome in patients listed for liver transplantation
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013

Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats
Source: Eur Respir J 2004; 23: 752-758
Year: 2004



Nitric oxide and beta2-adrenoceptor activation attenuate pulmonary vasoconstriction during anaphylactic hypotension in anesthetized BALB/c mice
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013


Nitric oxide metabolism in COPD comorbidities
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014

The effect of hyperglycemia on renal dysfunction associated with altered gene expression profiles in a rat model of mechanical ventilation
Source: Annual Congress 2013 –Mechanical ventilation and weaning
Year: 2013

Exhaled nitric oxide variations during oral challenge with different NSAIDs in patients with aspirin-induced asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016

Characterization of a new rat model of heritable PAH
Source: International Congress 2016 – Pulmonary hypertension: novel insights
Year: 2016


Effect of POL6014, a protein epitope mimetic (PEM) neutrophil elastase inhibitor, in a model of monocrotaline (MCT)-induced pulmonary arterial hypertension in rats
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013

Elastase-induced emphysema is attenuated by L-carnitine supplementation
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

An interim analysis of the phase III riociguat long-term extension study in CTEPH (CHEST-2)
Source: Annual Congress 2013 –Pulmonary circulation: treatment
Year: 2013


The role of soluble guanylyl cyclase in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases
Year: 2013



Use of different exhaled nitric oxide multiple flow rate models in COPD
Source: Eur Respir J 2007; 29: 651-659
Year: 2007



Over-expression of the LTC4 synthase gene in mice reproduces human aspirin-induced asthma (AIA)
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013

Human apyrase (APT102) treatment attenuates the development of severe pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013


The role of nitric oxide and cholinergic pathways in the cardiovascular and lung functional changes following chronic hypoxia
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013

The use of exhaled nitric oxide (NO) to categorize asthma phenotype and treatment in children - Results from National Hospital of Pediatrics
Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools
Year: 2018


Association of polymorphisms in renin-angiotensin-aldosterone system pathway, nitric oxide synthase 3 with acute mountain sickness
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013